Patent details

Basic Information

Publication number:

EP3099719

PCT Application Number:

US2015013410

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157034141

PCT Publication Number:

WO2015116753

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD)

French Title of Invention:

ANTICORPS CONTRE LE DOMAINE EXTRACELLULAIRE DE MUC1-C (MUC1-C/ECD)

German Title of Invention:

ANTIKÖRPER GEGEN DIE MUC1-C/EXTRAZELLULÄRE DOMÄNE (/MUC1-C/ECD)

SPC Number:

Dates

Filing date:

29/01/2015

Grant date:

01/04/2020

EP Publication Date:

07/12/2016

PCT Publication Date:

06/08/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/04/2020

EP B1 Publication Date:

01/04/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/01/2021

Expiration date:

29/01/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/03/2020

 

 

Name:

Dana-Farber Cancer Institute, Inc.

Address:

450 Brookline Avenue, Boston, MA 02215-5450, United States (US)

Name:

Genus Oncology, LLC

Address:

2458 N. Racine Avenue, Chicago, IL 60614, United States (US)

Inventor

1

Name:

KUFE, Donald, W.

Address:

United States (US)

2

Name:

KHARBANDA, Surender

Address:

United States (US)

Priority

Priority Number:

201461933001 P

Priority Date:

29/01/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; C07K 16/30;

Publication

European Patent Bulletin

Issue number:

202014

Publication date:

01/04/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages